S. Katti

发表

Human Beta Casein Fragment (54–59) Modulates M. bovis BCG Survival and Basic Transcription Factor 3 (BTF3) Expression in THP-1 Cell Line

W. Haq, Vandana Singh, R. Tripathi, 2012, PloS one.

Anti‐Stroke Profile of Thiazolidin‐4‐One Derivatives in Focal Cerebral Ischemia Model in Rat

Rajkumar Verma, S. B. Katti, R. Raghubir, 2011, Chemical biology & drug design.

Synthesis and Pharmacological Evaluation of Novel Arginine Analogs as Potential Inhibitors of Acetylcholine‐Induced Relaxation in Rat Thoracic Aortic Rings

M. Dikshit, W. Haq, M. Barthwal, 2012, Chemical biology & drug design.

Isolation, characterization and antifungal docking studies of wortmannin isolated from Penicillium radicum

Vineeta Singh, P. Somvanshi, S. Haque, 2015, Scientific Reports.

CoMFA and CoMSIA of diverse pyrrolidine analogues as dipeptidyl peptidase IV inhibitors: active site requirements

Y. S. Prabhakar, S. B. Katti, V. Murugesan, 2011, Molecular Diversity.

Design, Synthesis, Biological Screening, and Molecular Docking Studies of Piperazine‐Derived Constrained Inhibitors of DPP‐IV for the Treatment of Type 2 Diabetes

Akansha Mishra, W. Haq, A. Srivastava, 2015, Chemical biology & drug design.

SYNTHESIS AND FAB MASS SPECTROSCOPICAL STUDIES ON 2',5'-DINUCLEOSIDE-MONOPHOSPHATES

K. P. Madhusudanan, Anil Kumar, S. B. Katti, 1997 .

Normal Modes and Their Dispersion in α Poly(β-benzyl-L-aspartate)

P. Tandon, V. D. Gupta, S. B. Katti, 1996 .

QSAR Studies on Thiazolidines: A Biologically Privileged Scaffold

Y. S. Prabhakar, V. Solomon, M. Gupta, 2006 .

Design and synthesis of new antimalarial agents from 4-aminoquinoline.

K. Srivastava, S. Puri, V. Solomon, 2005, Bioorganic & medicinal chemistry.

2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.

Yenamandra S Prabhakar, Y. S. Prabhakar, Ravindra K Rawal, 2005, Bioorganic & medicinal chemistry.

Synthesis and biological evaluation of 4-thiazolidinone derivatives as potential antimycobacterial agents

W. Haq, S. Sinha, S. B. Katti, 2005 .

Graph theory concepts in the rationales of anti HIV-1 compounds.

Yenamandra S Prabhakar, Y. S. Prabhakar, Utsab Debnath, 2013, Current computer-aided drug design.

Crocetin-dialdehyde from Coleus forskohlii BRIQ., Labiatae†

C. Eugster, S. B. Katti, P. Rüedi, 1979 .

N,N-bis[2-oxo-3-oxazolidinyl]phosphorodiamidic chloride: a novel coupling reagent in the synthesis of oligodeoxyribonucleotides

S. B. Katti, K. Agarwal, S. Katti, 1985 .

Carbodiimide mediated synthesis of 4-thiazolidinones by one-pot three-component condensation

W. Haq, S. B. Katti, T. Srivastava, 2002 .

Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.

Ravindra K Rawal, Christophe Pannecouque, E. De Clercq, 2007, Bioorganic & medicinal chemistry.

Tryptophan residue is essential for immunoreactivity of a diagnostically relevant peptide epitope of A. fumigatus

W. Haq, T. Madan, S. B. Katti, 2005, Molecular and Cellular Biochemistry.

4-Aminoquinoline derived antimalarials: synthesis, antiplasmodial activity and heme polymerization inhibition studies.

K. Srivastava, S. Puri, V. Solomon, 2010, European journal of medicinal chemistry.

Consensus features of CP-MLR and GA in modeling HIV-1 RT inhibitory activity of 4-benzyl/benzoylpyridin-2-one analogues

Y. S. Prabhakar, M. Goodarzi, Rinki Singh, 2011, Journal of enzyme inhibition and medicinal chemistry.

CP‐MLR/PLS Directed Structure‐Activity Modeling of the HIV‐1 RT Inhibitory Activity of 2,3‐Diaryl‐1,3‐thiazolidin‐4‐ones

Ravindra K. Rawal, Manish K. Gupta, Yenamandra S. Prabhakar, 2004 .

Prophylactic and Therapeutic Potential of Asp f1 Epitopes in Naïve and Sensitized BALB/c Mice

G. Raghava, Anil Kumar, W. Haq, 2009, Immune network.

Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.

Ravindra K Rawal, Christophe Pannecouque, E. De Clercq, 2007, Bioorganic & Medicinal Chemistry.

Synthesis, Biological Evaluation and Molecular Modeling Studies of New 2,3‐Diheteroaryl Thiazolidin‐4‐Ones as NNRTIs

Y. S. Prabhakar, S. Gupta, U. Debnath, 2015, Chemical biology & drug design.

Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors.

R. Paranjape, S. Kulkarni, S. B. Katti, 2011, Bioorganic & medicinal chemistry.

Is Feature Selection Essential for ANN Modeling

Yenamandra S. Prabhakar, Y. S. Prabhakar, Mohammad Goodarzi, 2009 .

CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents.

Y. S. Prabhakar, S. B. Katti, V. Murugesan, 2009, Journal of molecular graphics & modelling.

Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.

Zhenhua Pan, Neerja Kaushik-Basu, P. Arora, 2008, Bioorganic & medicinal chemistry letters.

Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.

Ravindra K Rawal, Christophe Pannecouque, E. De Clercq, 2008, European journal of medicinal chemistry.

2‐(2,6‐Dihalo‐phenyl)‐3‐heteroaryl‐2‐ylmethyl‐1, 3‐thiazolidin‐4‐ones: Anti‐HIV agents

Ravindra K Rawal, Christophe Pannecouque, E. De Clercq, 2008, Chemical biology & drug design.

NEW PIPERAZINE-DERIVED NNRTIS AS ANTI-HIV AGENT: SYNTHESIS, BIOLOGICAL EVALUATION AND MOLECULAR DOCKING STUDIES

Satyandra K. Gupta, R. Tripathi, H. Siddiqui, 2015 .

Topological descriptors in modeling the HIV inhibitory activity of 2-aryl-3-pyridyl-thiazolidin-4-ones.

Y. S. Prabhakar, V. Solomon, R. Rawal, 2005, Combinatorial chemistry & high throughput screening.

Synthesis and QSAR studies on thiazolidinones as anti-HIV agents.

Y. S. Prabhakar, E. De Clercq, V. Solomon, 2005, Combinatorial chemistry & high throughput screening.

Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.

R. Paranjape, S. Kulkarni, V. Murugesan, 2014, Bioorganic & medicinal chemistry.

Discovery of 17 Gliptins in 17-Years of Research for the Treatment of Type 2 Diabetes: A Synthetic Overview

W. Haq, S. B. Katti, R. N. Kushwaha, 2014 .

Molecular docking studies on 4-thiazolidinones as HIV-1 RT inhibitors

Ashutosh Kumar, M. Siddiqi, R. Rawal, 2006, Journal of molecular modeling.